SAM
MRNA icon

Strategic Asset Management’s Moderna MRNA Stock Holding History

Strategic Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$3K Hold
25
– – 0.01% 520
2022
Q2 		$4K Hold
25
– – 0.01% 516
2022
Q1 		$4K Hold
25
– – 0.01% 481
2021
Q4 		$6K Sell
25
-20
-44% -$5.85K 0.01% 421
2021
Q3 		$14K Buy
+45
New +$16.6K 0.02% 294

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Strategic Asset Management's MRNA Position: Q3 2022 in Review

Strategic Asset Management held its Moderna (MRNA) position steady in Q3 2022 at 25 shares worth $3K. The position accounts for 0.01% of the portfolio, ranked #520.

Strategic Asset Management first reported a position in MRNA in Q3 2021 and has held it in 5 quarters since. The position peaked at $14K in Q3 2021. 915 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • Strategic Asset Management held 25 shares of Moderna worth $3K as of Q3 2022.
  • Strategic Asset Management left its Moderna share count unchanged in Q3 2022.
  • Moderna made up 0.01% of Strategic Asset Management's portfolio in Q3 2022, its #520 holding.
  • Strategic Asset Management first reported a position in Moderna in Q3 2021 and has held it in 5 quarters since.
  • Strategic Asset Management's Moderna position peaked at $14K in Q3 2021.
  • 915 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Strategic Asset Management's 13F filing for Q3 2022, filed 1 Nov 2022.